From nonalcoholic fatty liver to nonalcoholic steatohepatiti... : Current Opinion in Infectious
Diseases From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected …

Objective: To describe the prevalence and factors associated with nonalcoholic fatty liver
disease (NAFLD) among HIV-infected persons not infected with hepatitis C virus (HCV) …

Background Little is known about the importance of liver fibrosis and fatty liver in HIV‐
monoinfected individuals without hepatitis virus co‐infection, particularly among the Asian …

Background HIV-monoinfected patients may be at risk for significant liver fibrosis, but its
prevalence and determinants in these patients are unknown. Since HIV-monoinfected …

Background Transient elastography (TE) is a non-invasive method that allows liver fibrosis
staging on the basis of hepatic stiffness measurements. Little is known about the influence of …

Background The combination of transient elastometry with a controlled attenuation
parameter (CAP) is available to evaluate hepatic steatosis (HS) along with liver stiffness …

Introduction Since the development of antiretroviral therapy (ART) with TDF plus 3TC plus
EFV, this specific regimen has not been studied enough with long-term lipid and uric acid …

Objectives: Progressive liver injury is a concern in HIV-infected children exposed to long-
term antiretroviral drugs and to the cytopathic effect of HIV. Yet liver biopsy is usually …

Background Insulin resistance (IR), the major feature of the metabolic syndrome, is also
common in patients with chronic HCV infection. Liver fibrosis and steatosis are known …

Objective Multiple factors may lead to hepatic steatosis (HS) in HIV‐positive patients. HS
may result in severe liver damage on its own and/or by accelerating the progression of …